$ACUR
ACURA PHARMACEUTICALS, INC

2015 Q4 Form 10-Q Financial Statement

#000114420415062776 Filed on November 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $2.679M $210.0K $145.0K
YoY Change 406.43% 44.83% 74.7%
Cost Of Revenue $100.0K $130.0K $110.0K
YoY Change 150.0% 18.18% 37.5%
Gross Profit $2.580M $80.00K $40.00K
YoY Change 426.53% 100.0% 300.0%
Gross Profit Margin 96.3% 38.1% 27.59%
Selling, General & Admin $2.590M $2.024M $1.728M
YoY Change 26.96% 17.13% -10.97%
% of Gross Profit 100.39% 2530.0% 4320.0%
Research & Development $700.0K $430.0K $955.0K
YoY Change -23.08% -54.97% -25.91%
% of Gross Profit 27.13% 537.5% 2387.5%
Depreciation & Amortization $90.00K $90.00K $30.00K
YoY Change -52.63% 200.0% 0.0%
% of Gross Profit 3.49% 112.5% 75.0%
Operating Expenses $3.290M $2.024M $2.791M
YoY Change 10.25% -27.48% -15.63%
Operating Profit -$710.0K -$2.405M -$2.646M
YoY Change -71.08% -9.11% -17.95%
Interest Expense -$210.0K $283.0K $304.0K
YoY Change -12.5% -6.91%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$258.0K
YoY Change -100.0% -837.14%
Pretax Income -$920.0K -$2.649M -$2.904M
YoY Change -65.93% -8.78% -8.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$916.0K -$2.649M -$2.904M
YoY Change -66.02% -8.78% -8.97%
Net Earnings / Revenue -34.19% -1261.43% -2002.76%
Basic Earnings Per Share -$0.08 -$0.23 -$0.30
Diluted Earnings Per Share -$0.08 -$0.23 -$0.30
COMMON SHARES
Basic Shares Outstanding 11.80M shares 11.68M shares 48.92K shares
Diluted Shares Outstanding 11.68M shares 48.92K shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.32M $15.25M $14.56M
YoY Change 10.14% 4.74% -25.05%
Cash & Equivalents $2.485M $3.324M $1.250M
Short-Term Investments $10.84M $11.93M $13.31M
Other Short-Term Assets $2.910M $490.0K $950.0K
YoY Change 321.74% -48.42% 10.47%
Inventory $276.0K $70.00K $403.0K
Prepaid Expenses
Receivables $83.00K $170.0K $130.0K
Other Receivables $40.00K $50.00K $90.00K
Total Short-Term Assets $14.14M $16.03M $16.14M
YoY Change 6.83% -0.68% -22.28%
LONG-TERM ASSETS
Property, Plant & Equipment $1.013M $1.040M $960.0K
YoY Change 5.85% 8.33% -1.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $180.0K $180.0K $180.0K
YoY Change 0.0% 800.0%
Total Long-Term Assets $2.826M $2.910M $3.140M
YoY Change 0.86% -7.32% 215.26%
TOTAL ASSETS
Total Short-Term Assets $14.14M $16.03M $16.14M
Total Long-Term Assets $2.826M $2.910M $3.140M
Total Assets $16.96M $18.94M $19.28M
YoY Change 5.79% -1.76% -11.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $110.0K $280.0K $116.0K
YoY Change -49.31% 141.38% -54.15%
Accrued Expenses $564.0K $890.0K $1.488M
YoY Change -0.7% -40.19% 92.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.320M $2.470M $1.160M
YoY Change 31.97% 112.93%
Total Short-Term Liabilities $3.244M $3.840M $3.032M
YoY Change 8.42% 26.65% 172.91%
LONG-TERM LIABILITIES
Long-Term Debt $5.430M $6.040M $8.530M
YoY Change -30.38% -29.19%
Other Long-Term Liabilities $390.0K $340.0K $140.0K
YoY Change 105.26% 142.86% 1300.0%
Total Long-Term Liabilities $5.430M $6.380M $8.670M
YoY Change -30.38% -26.41% 86600.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.244M $3.840M $3.032M
Total Long-Term Liabilities $5.430M $6.380M $8.670M
Total Liabilities $9.061M $10.22M $11.70M
YoY Change -17.48% -12.65% 948.39%
SHAREHOLDERS EQUITY
Retained Earnings -$367.3M
YoY Change 1.38%
Common Stock $375.3M
YoY Change 2.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.900M $8.730M $7.580M
YoY Change
Total Liabilities & Shareholders Equity $16.96M $18.94M $19.28M
YoY Change 5.79% -1.76% -11.41%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$916.0K -$2.649M -$2.904M
YoY Change -66.02% -8.78% -8.97%
Depreciation, Depletion And Amortization $90.00K $90.00K $30.00K
YoY Change -52.63% 200.0% 0.0%
Cash From Operating Activities -$1.060M -$2.130M -$2.640M
YoY Change -54.89% -19.32% -15.38%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $50.00K -$60.00K
YoY Change -100.0% -183.33%
Acquisitions
YoY Change
Other Investing Activities $1.020M -$2.310M $400.0K
YoY Change -46.6% -677.5% -81.04%
Cash From Investing Activities $1.020M -$2.260M $350.0K
YoY Change -45.74% -745.71% -83.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -800.0K 6.450M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.060M -2.130M -2.640M
Cash From Investing Activities 1.020M -2.260M 350.0K
Cash From Financing Activities -800.0K 6.450M 0.000
Net Change In Cash -840.0K 2.060M -2.290M
YoY Change 78.72% -189.96% -216.84%
FREE CASH FLOW
Cash From Operating Activities -$1.060M -$2.130M -$2.640M
Capital Expenditures $0.00 $50.00K -$60.00K
Free Cash Flow -$1.060M -$2.180M -$2.580M
YoY Change -54.31% -15.5% -17.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-2649000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2646000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
283000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2405000 USD
CY2015Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
39000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1907000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6404000 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
5250000 USD
acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
554000 USD
us-gaap Inventory Write Down
InventoryWriteDown
334000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
2615000 USD
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
2791000 USD
CY2014Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
46000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
304000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2649000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2904000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2904000 USD
CY2015Q3 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
2000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
4000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
563000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
218000 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
us-gaap Revenues
Revenues
222000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
155000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10446000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9774000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10446000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9774000 shares
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
461000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 USD
acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
188000 USD
us-gaap Inventory Write Down
InventoryWriteDown
201000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3674000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5903000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9199000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9966000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3291000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9744000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
110000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
143000 USD
us-gaap Interest Expense
InterestExpense
892000 USD
us-gaap Interest Expense
InterestExpense
907000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-782000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-769000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4073000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10513000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-4073000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10513000 USD
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
2000 USD
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
6000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4071000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10507000 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
33000 USD
acur Issuance Of Common Stock Value Under Market Offerings
IssuanceOfCommonStockValueUnderMarketOfferings
217000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
92000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
334000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
201000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
461000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
716000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
144000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
140000 USD
acur Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
106000 USD
acur Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
201000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-5000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
171000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-62000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-15000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-28000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
104000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
353000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
183000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-217000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-46000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
175000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
59000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-158000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
257000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1087000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-353000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-59000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2632000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8685000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
141000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
529000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6091000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-520000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2550000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11089000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12340000 USD
us-gaap Interest Paid
InterestPaid
606000 USD
us-gaap Interest Paid
InterestPaid
557000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
253000 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-20000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3523000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2203000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2811000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2424000 USD
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 USD
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
2000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
211000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
105000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-909000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1884000 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
225000 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
611000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1160000 USD
CY2015Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
24000 shares
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Licenses Revenue
LicensesRevenue
250000 USD
CY2015Q3 acur Sales Returns Liability
SalesReturnsLiability
173000 USD
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3600000 USD
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3500000 USD
CY2015Q3 acur Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
1000000 USD
CY2014Q4 acur Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
2800000 USD
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11300000 USD
CY2015Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11900000 USD
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11900000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11300000 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2015Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
0 USD
CY2014Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
260000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
148000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
44000 USD
CY2015Q3 us-gaap Inventory Gross
InventoryGross
148000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
304000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
260000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
94000 USD
CY2015Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
269000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
253000 USD
CY2015Q3 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
10000 USD
CY2014Q4 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
13000 USD
CY2015Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
13000 USD
CY2014Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
15000 USD
CY2015Q3 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
57000 USD
CY2014Q4 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
83000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
96000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
49000 USD
CY2015Q3 acur Marketing And Promotion
MarketingAndPromotion
120000 USD
CY2014Q4 acur Marketing And Promotion
MarketingAndPromotion
61000 USD
us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
1160000 USD
acur Debt Instrument Classification Amount
DebtInstrumentClassificationAmount
0 USD
CY2014Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10000000 USD
CY2015Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8840000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
94000 USD
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
281000 USD
CY2015Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
220000 USD
CY2014Q4 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
-162000 USD
acur Additions To Debt Instrument Issuance Costs
AdditionsToDebtInstrumentIssuanceCosts
0 USD
acur Amortization Expense Of Debt Instrument Issuance Costs
AmortizationExpenseOfDebtInstrumentIssuanceCosts
50000 USD
CY2015Q3 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
-112000 USD
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
8508000 USD
CY2015Q3 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
31000 USD
CY2014Q3 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
30000 USD
CY2015Q3 us-gaap Debt Issuance Costs
DebtIssuanceCosts
16000 USD
CY2014Q3 us-gaap Debt Issuance Costs
DebtIssuanceCosts
17000 USD
CY2014Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
257000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
748000 USD
acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
94000 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
50000 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
51000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
767000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
598000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2741000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2522000 USD
acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
89000 USD
CY2015Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1016 pure
CY2013Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13000000 USD
CY2015Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2979000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 USD
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0835 pure
CY2013Q4 acur Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
0.1335 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
260000 USD
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2018-12-01
acur Additions To Debt Instrument Unamortized Discount
AdditionsToDebtInstrumentUnamortizedDiscount
33000 USD
CY2015Q1 acur Debt Instrument Cash Maintenance
DebtInstrumentCashMaintenance
2500000 USD
CY2015Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
5000000 USD
CY2015Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
50000 USD
acur Debt Consulting Placement Fee
DebtConsultingPlacementFee
100000 USD
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
231000 USD
us-gaap Sale Leaseback Transaction Transaction Costs Financing Activities
SaleLeasebackTransactionTransactionCostsFinancingActivities
8000 USD
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.52
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
111000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
172000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
344000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
546000 USD
CY2015Q3 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
150000 USD
CY2014Q3 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
229000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
461000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
716000 USD
CY2014 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
51500000 USD
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151400000 USD
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2900000 USD
CY2015Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11653000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
9770000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
10432000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
9769000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
14000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
14000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
5000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
965000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
802000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
965000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
802000 shares
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
ACURA PHARMACEUTICALS, INC
dei Entity Central Index Key
EntityCentralIndexKey
0000786947
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
ACUR
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11800986 shares
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
88000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
310000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
155000 USD
CY2015Q3 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
112000 USD
CY2014Q4 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
162000 USD
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11801000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11801000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9770000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9770000 shares
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2015Q1 acur Inventory Reserve For Raw Materials
InventoryReserveForRawMaterials
260000 USD
CY2014 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
13000 USD
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
95000 USD
CY2014Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
0 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
95000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
0 USD
acur Proceeds From Registered Direct Offering
ProceedsFromRegisteredDirectOffering
7636000 USD
acur Proceeds From Registered Direct Offering
ProceedsFromRegisteredDirectOffering
0 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
7032000 USD
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
60000 shares
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
255000 USD
CY2015Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
314000 USD
CY2015Q3 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
95000 USD
us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
217000 USD
CY2015Q1 acur Percentage Of Inventory Allowance Reserve
PercentageOfInventoryAllowanceReserve
1 pure
CY2015Q4 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
1360000 USD
CY2015Q3 us-gaap Retail Related Inventory
RetailRelatedInventory
260000 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
74000 USD
us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
1840000 USD
CY2014 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
1790000 USD

Files In Submission

Name View Source Status
0001144204-15-062776-index-headers.html Edgar Link pending
0001144204-15-062776-index.html Edgar Link pending
0001144204-15-062776.txt Edgar Link pending
0001144204-15-062776-xbrl.zip Edgar Link pending
acur-20150930.xml Edgar Link completed
acur-20150930.xsd Edgar Link pending
acur-20150930_cal.xml Edgar Link unprocessable
acur-20150930_def.xml Edgar Link unprocessable
acur-20150930_lab.xml Edgar Link unprocessable
acur-20150930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v422457_10q.htm Edgar Link pending
v422457_ex31-1.htm Edgar Link pending
v422457_ex31-2.htm Edgar Link pending
v422457_ex32-1.htm Edgar Link pending